Press Release
Release date: October 1, 2007
Codexis Announces Four New Codex(TM) Biocatalyst Panels
Expands Portfolio of R&D Productivity Tools for Fast, Efficient Pharmaceutical Process Development; Launched at CPhI This Week
REDWOOD CITY, Calif., Oct. 1 /-- Codexis, Inc., a leading developer of clean, biobased manufacturing technologies, today expanded its portfolio of Codex(TM) Biocatalyst Panels. The company announced four new panels covering classes of enzymes that can produce a broad range of chemicals widely used by the pharmaceutical industry. The panels will be launched this week at the 2007 CPhI (Convention of Pharmaceutical Ingredients and Intermediates) conference in Milan, Italy (Oct. 2-4, http://www.cphi.com/).
In February, Codexis introduced the first panel, the Codex(TM) KRED Panel for development of new biocatalyst-based manufacturing processes for chiral alcohols. Biocatalysts enable development of environmentally-friendly, low cost methods to produce chirally pure chemicals and have already replaced chemo-catalysts in certain processes. With the announcement this week, Codexis will offer panels for 4 additional enzyme classes which can be used for producing the molecules shown in the chart below. The Codex(TM) Acylase and Codex(TM) ERED panels will be available in the fourth quarter of 2007; the remaining panels in the first quarter of 2008.
Enzyme Class Products
Acylases (Codex(TM) Acylase) Chiral amines or alcohols via
resolution of amides or esters
Ene reductases (Codex(TM) ERED) alpha and/or beta chiral
ketones, esters and nitriles
Transaminases (Codex(TM) TA) Chiral amines
Halohydrin dehalogenases (Codex(TM) HHDH) Chiral halohydrins,
cyanohydrins, amino alcohols,
epoxides, diols
"Since their launch in February, customers have used the Codex(TM) KRED Panel to move from initial screening to generating the first kilogram quantities of a target material in a matter of weeks -- a substantial reduction in development time," said Peter Seufer-Wasserthal, Ph.D., Vice President and General Manager, Codexis Pharma Services Group. "Panel data can be integrated early in the research process, dramatically reducing the time required by pharmaceutical process chemists to generate a cost-effective, efficient biocatalyst for a desired reaction."
The Codex(TM) Biocatalyst Panels are next-generation research products that enable pharmaceutical manufacturers to harness the power of directed evolution by providing biocatalysts that can increase R&D and manufacturing productivity while significantly reducing cost. Sets of diagnostic enzyme panels are provided in a convenient 96-well format to efficiently determine if a biocatalytic solution is available for a challenging process step in the production of active pharmaceutical ingredients and intermediates needed to produce human therapeutics. Panel data is then used to rapidly develop product-specific, customized biocatalysts and biocatalytic processes for Codexis' pharmaceutical partners.
Codexis, Inc., a private biotechnology company, is a leading developer of biocatalytic chemical technologies that can dramatically reduce the cost of manufacturing across a broad range of industries. Codexis technologies enable novel solutions for efficient, cost-effective and environmentally-friendly processes for pharmaceutical, energy and industrial chemical applications. In 2006, the company was recognized by the U.S. EPA with a Presidential Green Chemistry Challenge Award for developing an environmentally friendly, low-cost alternative manufacturing process. Codexis began operations in 2002. For more information, see http://www.codexis.com/.
CONTACT: Lyn Christenson of Codexis, Inc., +1-650-298-5368, lyn.christenson@codexis.com
Web site: http://www.codexis.com/
Contacts:
General Information:
Lyn Christenson
USA
Phone: 650-298-5368
 E-mail this person
Company Information:
Name: Codexis, Inc.
Address: 200 Penobscot Drive
City: Redwood City,
State: CA
ZIP: 94063,
Country: USA
Phone: 650-980-5600
http://www.codexis.com/
|
|
|
Advertisement
|
|
| Related Stories: | | Apr 30, 2008 | Genetic Tool facilitates experimental processes. |
| Feb 5, 2008 | System enables protein function analysis. |
| Aug 17, 2007 | Enterovirus Controls enables standardized testing. |
| Mar 14, 2007 | Quantification System provides RNA detection. |
| Feb 27, 2007 | Development Kits suit wired/wireless embedded networking. |
| Jan 16, 2007 | Software provides web-based clinical trial management. |
| Sep 15, 2006 | Testing Products facilitate creation of HOT applications. |
| Sep 7, 2006 | HPLC Columns target preparative R&D applications. |
| Aug 30, 2006 | Protease Enzyme targets ethanol industry. |
| Nov 23, 2005 | Development Platform targets software-defined radio projects. |
| Aug 5, 2005 | Pocket-Size Instrument automates electrophysiology. |
| Jun 10, 2005 | Eye Tracking System offers entry-level, upgradeable solution. |
| May 20, 2005 | Remote Eye Tracking System eliminates use of headware. |
| May 19, 2005 | Digital Camera supports MAC and Windows platforms. |
| Sep 9, 2004 | Eye Tracking System features lightweight optics. |
| Apr 29, 2003 | Display Panel suits mobile-machine development. |
| |
| |
|
|
|
![[Get Copyright Permissions]](http://license.icopyright.net/images/icopy-w.gif){kind=small}
